CHDRFKB

Factor Information
Data ID	705
Factor	Hemoglobin
Description	N/A
Biomarker	NA
Classification	E11 (physiological factor - physical sign)

Association
Application	prognosis
Objective	APAH-CHD
p Value	<0.001
Conclusion	Patients with Eisenmenger syndrome showed more increased in hemoglobin.
Risk Factor	unknown

Reference
PMID	28966315
Year	2017
Title	Prognostic Value of Pulmonary Artery Compliance in Patients with Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease

Sample
Population	adult
Source	data
Region	China, Beijing
Method	T-test and analysis of variance
Race	Asian
Disease History	N/A
Treatment History	cardiac operation
Group	Eisenmenger syndrome(Treatment)	PAH with small defects; PAH after defect correction(Control)
Number	112	20(PAH with small defects); 43(PAH after defect correction)
Age	29±9 years	32±11 years(PAH with small defects); 26±9 years(PAH after defect correction)
Gender (Male: Female)	33:79	4:16(PAH with small defects); '9:34(PAH after defect correction)
Marker Level	164.6±23.9 g/L	149.6±17.5g/L(PAH with small defects);142.0±22.2g/L(PAH after defect correction)